about
IBD-related work disability in the community: Prevalence, severity and predictive factors. A cross-sectional study.Development and Validation of the Short Crohn's Disease Work Disability Questionnaire.Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study.[Incidence of inflammatory bowel disease in Aragon: outcome of a prospective population-based study][Helicobacter pylori resistance to metronidazole and clarythromicin: descriptive analysis 1997-2000].Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.Ustekinumab for the Treatment of Refractory Crohn's Disease: The Spanish Experience in a Large Multicentre Open-label Cohort.Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study.Therapeutic guidelines on ulcerative colitis: a GRADE methodology based effort of GETECCU.Factors affecting the variation in antibiotic resistance of Helicobacter pylori over a 3-year period.Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registryValidation of a self-reported work disability questionnaire for ulcerative colitisErratum: Corrigendum: Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC StudyCirugía de una cohorte incidente de pacientes con enfermedad de Crohn en Aragón: indicaciones, tipo de cirugía y factores de riesgo asociadosLa afectación pancolónica inicial en la colitis ulcerosa predice la necesidad de colectomía: estudio poblacional basado en una cohorte incidente de pacientes en AragónThird line treatment for Helicobacter pylori: a prospective, culture-guided study in peptic ulcer patients[Epidemiology of inflammatory bowel disease: controversies in classical epidemiology][No best treatment for severe outbreaks: Maintenance, the key in colitis][Epidemiology, diagnosis, complications and surgery in inflammatory bowel disease]
P50
Q35926068-83C61463-905B-439E-A134-6356E0DB53D8Q39557707-C03C9AF7-0E23-4942-AED2-ECD9654C27ACQ40876904-621FF7A9-44D0-4906-9C95-E7184F40137BQ45095848-3A563B14-0813-4CB6-AE7B-2E5AD3B66363Q45128946-8DE64AE1-A88D-4B18-9847-A145206D5B2FQ48904882-F4B7AC38-FE42-4ED2-B54D-6DC199C3D2E8Q50237402-F3136C1E-E8FF-42F9-8F58-F79EF90DAB83Q50271028-471FCA71-2CC6-4CBD-8815-91C7C3A4C279Q50496615-355F74FE-C5BD-4117-AA85-434207E1DBE1Q54028916-FF3EC7C4-514C-4CB9-828A-80147CFC6C63Q57051384-8B28E652-90D9-4937-9B53-EAD945BD3F6BQ57127769-6C4FFFCF-CF6B-4E79-A515-4FFE5873D9B2Q61962899-2EDC77F4-801D-412F-8BF5-36A990CA9C9AQ62759562-0DCF26C0-3040-4B62-A4B2-70FB5C414B10Q62759575-A9B9BCD3-7241-458B-8508-F093636A7519Q73023486-11CB47E4-95A0-4F1D-94E2-3E61A8A32237Q84369668-5DFDCA41-4346-4A18-8C84-B74FBCD4467BQ86097514-D23FBF47-A0A9-4579-A6DE-F778729C2CE1Q87388052-7B482CEC-8BF9-472C-A38B-EC8F9981777C
P50
description
researcher
@en
name
B Sicilia
@en
B Sicilia
@nl
type
label
B Sicilia
@en
B Sicilia
@nl
prefLabel
B Sicilia
@en
B Sicilia
@nl
P106
P31
P496
0000-0002-4495-9358